Codify — Article

Black Lung Benefits Improvement Act of 2025 (S.3491): Key reforms to claims, evidence, and trust-fund rules

Creates an on‑demand federal medical-evidence program, broadens presumptions for complicated pneumoconiosis, funds attorney help, indexes benefits to CPI, and tightens self‑insurance rules.

The Brief

The bill overhauls how claims under the Black Lung Benefits Act are developed and decided. It requires the Department of Labor to provide claimants a funded “complete pulmonary evaluation,” authorizes CT scans in certain cases, creates a publicly available list of qualified physicians with conflict-of-interest safeguards, and establishes expedited programs to pay modest attorneys’ fees and unreimbursed medical expenses from the Black Lung Disability Trust Fund.

The measure also (1) creates an irrebuttable presumption of total disability or death when imaging/biopsy shows complicated pneumoconiosis or progressive massive fibrosis, (2) restores automatic annual cost‑of‑living increases to benefits starting in 2026 tied to the CPI, (3) permits readjudication where prior negative radiographs were rendered by discredited physicians, and (4) strengthens financial requirements and penalties for operators that self‑insure. Those changes shift evidence development onto the Department and the Trust Fund while placing new financial and compliance obligations on operators and physicians.

At a Glance

What It Does

The bill requires the Secretary of Labor to provide and pay for complete pulmonary evaluations for claimants and, when initial exams suggest advanced disease, authorize CT scans. It creates an irrebuttable presumption when certain imaging or tissue findings show complicated pneumoconiosis, establishes a capped fee/expense payment program paid from the Trust Fund, and tightens rules and penalties for operator self‑insurance.

Who It Affects

Coal miners filing black‑lung claims and their survivors; physicians who interpret chest imaging (qualification and conflict disclosures); operators that self‑insure or insure liabilities; attorneys representing claimants; and the Black Lung Disability Trust Fund, which will advance evaluation and fee payments and seek reimbursement.

Why It Matters

The bill changes who builds the medical record (the Department becomes an active developer), lowers the evidentiary hurdle for proven advanced disease, and creates financial pathways for representation — all designed to speed awards but also to increase short‑term Trust Fund outlays and impose new regulatory and fiscal compliance on operators.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

S.3491 reorganizes the mechanics of black‑lung claims around two core moves: (1) make the Department of Labor an active developer of the medical record for claimants and (2) recalibrate legal and financial incentives so meritorious claims are more likely to result in timely awards. To do that, the Secretary must offer a claimant a “complete pulmonary evaluation” by a physician drawn from a Department list; that exam must follow formulaic components and, if certain radiographic findings appear, the Secretary must authorize a high‑quality low‑dose or standard CT scan.

The Secretary will pay expenses for these evaluations from the Black Lung Disability Trust Fund and later seek reimbursement from any liable operator that ultimately must pay benefits.

The bill expands the statutory presumption ladder: a chest radiograph, CT, biopsy, autopsy, or other medically accepted test that shows a lesion or large opacity over 1 cm consistent with complicated pneumoconiosis or progressive massive fibrosis creates an irrebuttable presumption the miner was totally disabled by (or died from) pneumoconiosis. The text specifies imaging thresholds (largest diameter >1 cm) and cross‑references ILO classification categories, while allowing CT and biopsy to substitute for radiographs where more probative evidence is absent.Procedurally, the statute creates several administrative tools.

It requires the Secretary to keep and publish a vetted list of qualified physicians, with annual suitability reviews and conflict‑of‑interest rules (including a 24‑month lookback on prior retention by opposing parties). It empowers the Department to develop supplemental reports if opposing evidence emerges, and it bars physicians employed by or recently retained by opposing parties from performing funded evaluations.

The bill also authorizes administrative sanctions and criminal penalties for false statements or obstructive conduct, mandates the Department to propose and finalize implementing regulations within fixed time frames, and allows claimants harmed by previously discredited negative readings to file new claims that exclude those radiographs from adjudication.On benefits and funding, the bill restores automatic annual adjustments to benefit rates using the Consumer Price Index beginning with a fixed 2026 base amount ($9,627.60 per year, paid monthly), replaces the GS‑2 pay‑rate tie, and establishes an attorneys’ fees and medical‑expense payment program for contested claims that remain undecided for two years. That program caps amounts the Secretary will pay per claim (up to $4,500 total in attorneys’ fees and up to $3,000 for medical expenses) and requires operators ultimately liable to reimburse the Trust Fund.

Finally, the bill strengthens self‑insurance oversight by directing interim and final rules (60 days and 12 months respectively), setting financial‑fitness criteria and security review procedures, and substantially raising statutory civil penalties and expanding the set of “responsible parties.” These provisions are intended to reduce operator defaults that have shifted costs onto the Trust Fund.

The Five Things You Need to Know

1

The bill creates an irrebuttable presumption of total disability or death from pneumoconiosis when imaging (chest x‑ray or CT) or pathology shows one or more large opacities >1 cm consistent with complicated pneumoconiosis or progressive massive fibrosis.

2

The Secretary must offer and fund a claimant’s complete pulmonary evaluation from a Department‑maintained list of qualified physicians and may authorize a CT scan when certain radiographic findings appear; those exam costs are paid by the Black Lung Disability Trust Fund and reimbursed by liable operators if benefits are awarded.

3

S.3491 establishes a Trust Fund‑paid attorneys’ fees and unreimbursed medical‑expense program for qualifying contested claims (contested claims unresolved after 2 years), with per‑claim caps: up to $4,500 in attorneys’ fees and up to $3,000 in medical expenses, and smaller interim approvals at district director and administrative law judge levels.

4

Benefit rates are uncoupled from the GS‑2 pay rate and set to a 2026 base ($9,627.60/year), after which annual increases are tied to the Consumer Price Index for Urban Wage Earners and Clerical Workers.

5

The bill tightens self‑insurance rules: it requires interim (60 days) and final (12 months) rules establishing financial‑fitness criteria and security reviews, raises civil penalties for failing to secure payment from $1,000 to $25,000, and expands the definition of responsible parties (including executives and commonly controlled entities).

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Sec. 101 (30 U.S.C. 937(a) amendment)

Expanding federally funded clinical assistance for claimants

This amendment broadens the Department’s statutory authority to provide analysis, examination, and treatment of respiratory impairments to include explicit assistance with claims for miners and their families. Practically, it shifts the Department’s role from clinical support alone to an integrated clinical‑claims role, authorizing healthcare services to be tied to claim development and outreach for dependents as well.

Sec. 102 (30 U.S.C. 921(c) amendment)

Irrebuttable presumption for complicated pneumoconiosis and PMF

The bill replaces the prior paragraph with a detailed standard: complicated pneumoconiosis/PMF may be established by chest radiograph, CT, biopsy/autopsy, or other medically accepted tests showing a lesion/opacity >1 cm. The statutory text cross‑references the ILO radiograph categories and explicitly permits CT and pathology to substitute for radiographs where radiographs are not the most probative evidence — a change that narrows grounds for denial based solely on earlier negative x‑ray readings.

Sec. 103 (new 30 U.S.C. 435)

Department development of medical evidence, CT authorization, and physician list

This new provision mandates that, on claimant request, the Secretary provide an initial complete pulmonary evaluation and, where conditions later warrant, supplemental medical reports. It requires authorization of low‑dose or standard CT scanning if B‑reader interpretations meet specific thresholds and creates a public list of qualified physicians subject to annual reviews, National Practitioner Data Bank checks, and conflict‑of‑interest disclosure rules (including exclusion where the physician works for or has been retained by an opposing party within 24 months). The fund pays evaluation costs upfront, but operators are required to reimburse the fund after a final award.

4 more sections
Sec. 104 (amending 30 U.S.C. 941)

Criminal penalties, disqualification, and discovery sanctions

The statute expands conduct‑based enforcement: false statements and coercive behavior are felonies (up to 5 years and fines), and attorneys or expert witnesses who engage in such conduct face permanent disqualification from black‑lung proceedings. Administrative law judges gain explicit discovery‑sanction authority (adverse inference, limitation of defenses, or default). The Secretary must publish proposed and final rules setting implementing procedures (proposed within 180 days; final within 18 months).

Sec. 105 (new 30 U.S.C. 436)

Readjudication where prior negative radiographs came from discredited readers

If a chest radiograph in a claim was read negative by a physician later determined by the Secretary to be non‑credible, the claimant or a surviving party may file a new claim that excludes that radiograph from adjudication. New claims are adjudicated on the merits, but the Secretary can deny them where an opposing party proves by clear and convincing evidence that the discredited radiograph played no role in prior denials. Filing is limited to claims that were finally denied by specified administrative actors.

Sec. 106 (new 30 U.S.C. 403)

Attorneys’ fees and unreimbursed medical‑expense payment program

The Secretary must create a program (180 days to implement) to pay modest, capped fees and unreimbursed medical expenses from the Trust Fund for contested claims unresolved after two years. The scheme authorizes district‑director and ALJ approvals at set ceilings ($1,500 and $3,000 at specific steps) and overall per‑claim caps ($4,500 fees; $3,000 medical). If an operator is ultimately liable, it must reimburse the fund; the program does not preclude additional fee awards a court or judge might order.

Secs. 107–108 and Sec. 131

Benefit CPI indexing, earnings disclosure, and self‑insurance rules and penalties

Section 412(a) replaces the GS‑2 tie with a fixed 2026 base annual rate and a CPI‑based annual adjustment formula thereafter. The bill amends tax and SSA disclosure authorities so the Department can obtain earnings and employer information for claims. For self‑insurance, the Secretary must issue an interim rule in 60 days and a final rule in 12 months setting financial‑fitness criteria, annual security calculations, and appeal procedures; statutory penalties for failing to secure payment jump to $25,000 and the definition of responsible parties is broadened to capture executives and commonly controlled entities.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Healthcare across all five countries.

Explore Healthcare in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Claimants (miners and survivors) — Gain funded, standardized complete pulmonary evaluations (including CT when indicated), easier paths to awards where advanced disease is proven, and access to capped fee and expense payments to secure representation and evidence development. This reduces out‑of‑pocket burdens and evidentiary inequality.
  • Unrepresented or under‑resourced claimants — The program lowers the hurdle to obtain medical evidence and modestly subsidizes attorney engagement in long‑running contested claims, increasing the likelihood that meritorious but resource‑poor claimants will proceed with effective representation.
  • Families and survivors of miners previously denied due to discredited radiograph readers — Those individuals can file new claims that exclude discredited readings, creating an avenue to relief without starting from scratch, subject to specified limits and a high standard for opponents to block readjudication.
  • Attorneys who represent claimants — Receive programmatic payments for work and expenses in qualifying delayed cases, making representation economically more viable in cases that otherwise would be unattractive.
  • Public health and regulatory agencies (DOL, OWCP) — Obtain statutory authority, data access (tax and SSA earnings), and rulemaking timelines to standardize evidence development and improve adjudicative throughput, centralizing medical evaluation under federal oversight.

Who Bears the Cost

  • Operators and self‑insurers (coal companies) — Face new upfront security assessments, tighter financial‑fitness criteria, higher civil penalties for failure to secure benefits, potential reimbursement obligations to the Trust Fund for evaluation and fee program payments, and greater exposure when corporate affiliates are captured as ‘other responsible parties.’
  • Black Lung Disability Trust Fund (temporarily) — Must front costs for medical evaluations and payments to attorneys/medical expenses; the fund is statutorily required to seek reimbursement but bears cash‑flow and actuarial risk until collections occur.
  • Qualified physicians — Must submit to suitability reviews, disclose conflicts, and may be excluded if they have recent ties to opposing parties; administrative burden and the risk of being removed from the list increase.
  • Federal adjudicators and OWCP staff — Will need additional resources to implement new lists, process supplemental reports, manage readjudications, and comply with fixed regulatory deadlines; the bill requires resource planning and reporting to Congress.
  • Insurers and claim‑opposing parties — Will face expanded investigatory and disclosure obligations and may incur higher litigation costs due to Department‑sponsored supplemental reports and readjudications.

Key Issues

The Core Tension

The central dilemma is trade‑off between accelerating access to benefits for disadvantaged claimants by having the federal government develop and pay for medical evidence, versus preserving fiscal integrity and procedural safeguards: shifting costs to the Trust Fund and giving claimants easier evidentiary pathways speeds relief but increases short‑term Fund outlays, regulatory complexity, and potential for relitigation — while stringent checks to prevent abuse (disqualification, conflict rules, reimbursement obligations) risk narrowing provider capacity and chilling advocacy.

The bill deliberately shifts evidence development costs and some litigation‑support functions onto the Department and the Black Lung Disability Trust Fund. That expedites access for unrepresented miners but creates a short‑term cash‑flow and actuarial exposure for the Fund that depends on successful later reimbursement from operators; where operators are insolvent or gone, reimbursement may be illusory.

The statutory reimbursement requirement is helpful but not an immediate credit substitute, and the Trust Fund will need operational rules and appropriations planning to manage expanded fronting.

Readjudication for claims tainted by discredited radiograph readers rectifies past procedural unfairness but risks a surge of filings and relitigation of long‑closed claims. The bill attempts to cabin that risk by excluding the discredited films from the new adjudication and permitting denial only where opponents show by clear and convincing evidence that the radiograph did not contribute to prior denials.

Still, administrative capacity limits and the potential for duplicative medical testing could lengthen processing times before the other reforms take effect. Implementation of the physician‑list rules also raises important design choices: aggressive conflict rules improve perceived neutrality but shrink the available pool of specialists, while conservative rules preserve capacity but risk continued private‑party influence.

Finally, criminal and permanent disqualification penalties for attorneys and experts are strong deterrents against misconduct, but they create the risk of chilling vigorous advocacy or expert participation if safeguards and clear procedural standards for investigation and appeal are not carefully implemented. Oversight, funding, and tightly written implementing regulations will determine whether the balance the bill seeks actually materializes in practice.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.